| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.008 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.009 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.009 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.097 | 0.01 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.097 | 0.01 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.01 |